➤ Get the DrugPatentWatch Daily Briefing

Get Daily Updates on Generic Entry, Litigation, Biosimilars, and more …

Serving leading biopharmaceutical companies globally:

Boehringer Ingelheim
McKesson
Dow
Mallinckrodt
Medtronic
Merck

Last Updated: September 22, 2021

DrugPatentWatch Database Preview

Claims for Patent: 10,017,768

➤ Get the DrugPatentWatch Daily Briefing

« Back to Dashboard

Summary for Patent: 10,017,768
Title:Method of treatment of chlamydial infections with selected EGFR inhibitors
Abstract: The present invention provides compositions and methods of use in the treatment/prevention of chlamydial infection and/or diseases and disorders associated with chlamydial infection in a subject.
Inventor(s): Tsang; Allen W. (Clemmons, NC), Furdui; Cristina M. (Clemmons, NC)
Assignee: Wake Forest University Health Sciences (Winston-Salem, NC)
Application Number:15/153,401
Patent Claims:1. A method of treating a vaginal chlamydial infection or pelvic inflammatory disease in a subject, comprising administering to the subject an effective amount of Erlotinib, Cetuximab, Gefitinib, Lapatinib, Canertinib, Vandetanib and any combination thereof.

2. The method of claim 1, further comprising administering to the subject an antibiotic, a chemotherapeutic agent, an anti-inflammatory agent, an immunomodulatory agent and/or radiation, in any combination.

Details for Patent 10,017,768

Applicant Tradename Biologic Ingredient Dosage Form BLA Number Approval Date Patent No. Assignee Estimated Patent Expiration Status Orphan Source
Imclone ERBITUX cetuximab VIAL; INTRAVENOUS 125084 001 2004-06-18 ⤷  Free Forever Trial Wake Forest University Health Sciences (Winston-Salem, NC) 2033-09-13 RX Orphan search
>Applicant >Tradename >Biologic Ingredient >Dosage Form >BLA >Number >Approval Date >Patent No. >Assignee >Estimated Patent Expiration >Status >Orphan >Source

International Patent Family for US Patent 10,017,768

Country Patent Number Estimated Expiration
Canada 2923837 ⤷  Free Forever Trial
European Patent Office 3043817 ⤷  Free Forever Trial
Mexico 2016003293 ⤷  Free Forever Trial
United States of America 2015079079 ⤷  Free Forever Trial
United States of America 2017067059 ⤷  Free Forever Trial
World Intellectual Property Organization (WIPO) 2015038755 ⤷  Free Forever Trial
>Country >Patent Number >Estimated Expiration

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Express Scripts
McKinsey
Dow
Merck
Mallinckrodt
Medtronic

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.